Immune Thrombocytopenia News and Research

RSS
SARS-CoV-2 Spike may trigger production of antibodies that cross-react with human thrombopoietin to induce thrombocytopenia

SARS-CoV-2 Spike may trigger production of antibodies that cross-react with human thrombopoietin to induce thrombocytopenia

Iron chelating properties of eltrombopag in pediatric acute myeloid leukemia

Iron chelating properties of eltrombopag in pediatric acute myeloid leukemia

mRNA COVID-19 vaccines may increase patients' concerns about side effects

mRNA COVID-19 vaccines may increase patients' concerns about side effects

Little evidence for mRNA COVID-19 vaccine-associated thrombocytopenia, suggests new FDA study

Little evidence for mRNA COVID-19 vaccine-associated thrombocytopenia, suggests new FDA study

Pfizer-BioNTech vaccination not associated with platelet activation in new study

Pfizer-BioNTech vaccination not associated with platelet activation in new study

Early treatment may prevent clotting in COVID-19 vaccine-related thrombocytopenia

Early treatment may prevent clotting in COVID-19 vaccine-related thrombocytopenia

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks

Phase 3 study to test efficacy of new treatment for pediatric acute-onset neuropsychiatric syndrome

Phase 3 study to test efficacy of new treatment for pediatric acute-onset neuropsychiatric syndrome

Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

Repurposed drug for acute lung injury in COVID-19

Repurposed drug for acute lung injury in COVID-19

Research reveals genetic variants linked to treatment-related complications in children with blood diseases

Research reveals genetic variants linked to treatment-related complications in children with blood diseases

Manchester researchers demonstrate safety, effectiveness of eltrombopag treatment in children with ITP

Manchester researchers demonstrate safety, effectiveness of eltrombopag treatment in children with ITP

Novartis receives FDA approval for expanded use of Promacta for younger children with rare blood disorder

Novartis receives FDA approval for expanded use of Promacta for younger children with rare blood disorder

New study may help identify novel ways to treat immune thrombocytopenia

New study may help identify novel ways to treat immune thrombocytopenia

Novartis announces FDA approval of Promacta for treatment of children with chronic ITP

Novartis announces FDA approval of Promacta for treatment of children with chronic ITP

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Study opens door to new treatment for hard-to-treat asthmatic children

Study opens door to new treatment for hard-to-treat asthmatic children

Rigel Pharmaceuticals reports net loss of $22.3 million for fourth quarter 2014

Rigel Pharmaceuticals reports net loss of $22.3 million for fourth quarter 2014

Study confirms safety of two measles-containing vaccines

Study confirms safety of two measles-containing vaccines

ANMAT approves Genzyme’s Lemtrada for treatment of relapsing remitting multiple sclerosis

ANMAT approves Genzyme’s Lemtrada for treatment of relapsing remitting multiple sclerosis